Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer
Condition(s):Metastatic Non-Small Cell Lung Carcinoma; Metastatic Colorectal Cancer; Metastatic Breast CancerLast Updated:February 7, 2024Completed